19 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
Act of 1977, as amended, the UK Bribery Act 2010 or any similar Law; or (d) made any unlawful bribe, rebate, payoff, influence payment, kickback
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
and regulations thereunder (the “FCPA”), or any other applicable anti-bribery or anti-corruption laws (the “Anti-Corruption Laws”) including, without limitation
8-K
EX-1.2
1mjs jeg408yne6u
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-10.1
2anqr6snijng vv
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
vaq56at7gukl7r0mskh
22 Mar 19
Annual report
4:45pm
424B4
5769r
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
q2v5fa
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
EX-1.1
xy5vwtunvy1tkzq7ts
23 Jan 19
IPO registration (amended)
4:39pm
S-1
d7pm3gay5d hb1
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.17
7uyv827w
21 Dec 18
IPO registration
4:39pm
DRS/A
du9zj9o7fdnrh2ixh4g
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
EX-10.13
6f7288ntfm 5sg
11 Oct 18
Draft registration statement
12:00am
DRS
0iw9byfq1
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next